Welcome and introduction, Otto Cars, ReAct

The antibiotic resistance crisis, Otto Cars, ReAct

EU policy processes, Nabil Safrany, EU Commission DG SANCO

How difficult is it to discover new antibiotics? Lynn Silver, LL Silver Consulting

The role of diagnostics in the management of antibiotic resistance, Anna Zorzet, ReAct & Isabelle Caniaux bioMerieux (due to technical problems Isabelle Caniaux is missing on the video)

Views on roles and responsibilities of the pharmaceutical industry, Richard Bergström, EFPIA

Exploring responses to the lack of new antibiotics: how do different incentives compare? Chantal Morel, London School of Economics

Views on the possibilities for open source collaboration, Bernard Munos, InnoThink Center for Research in Biomedical Innovation (due to technical problems only half of presentation on the video)